The impact of current infection levels on the cost-benefit of vaccination
When considering a new vaccine programme or modifying an existing one, economic cost-benefit analysis, underpinned by predictive epidemiological modelling, is a key component. This analysis is intimately linked to the willingness to pay for additional QALYs (quality-adjusted life-years) gained; curr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Epidemics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1755436516300706 |